KRAS-Mutant Pancreatic CancerPhase 1NCT07671339
ELI-002 7P + mFOLFIRINOX ± Tislelizumab
ELI-002 7P, With or Without Tislelizumab, in People With Pancreatic Cancer
ONT01 and Gemcitabine/Nab-paclitaxel as Second Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma
What the film says
This trial is for adults with metastatic pancreatic cancer, as a second line treatment.
The idea: ONT01 is a drug that activates CD11b, a protein on immune cells. The researchers think this can reprogram the area around the tumor to overcome resistance to immunotherapy. It is given with standard gemcitabine and nab paclitaxel chemotherapy.
The study looks at dose and safety, to prepare for future studies adding PD-1 immunotherapy.
This phase 1 and 2 study plans 61 patients. At Washington University School of Medicine in St. Louis, Patrick Grierson leads it.
Public record; not medical advice.
Sources behind this film
Adults; metastatic PDAC; second line; CD11b agonism reprograms TME to overcome resistance; gemcitabine + nab-paclitaxel; Dose; prior to future PD-1 studies; Phase 1/2; 61; WashU; Patrick Grierson
The drug
The dose of nab-paclitaxel is 125 mg/m^2.
The dose of gemcitabine is 1000 mg/m^2.
The study
The investigators hypothesize that CD11b agonism reprograms the tumor microenvironment (TME) to overcome resistance to checkpoint immunotherapy in pancreatic ductal adenocarcinoma (PDAC). Therefore, the investigators propose an open label phase I/II clinical trial of ONT01 with gemcitabine and nab-paclitaxel in unresectable pancreatic ductal adenocarcinoma prior to future studies incorporating anti-PD1 checkpoint immunotherapy.
Eligibility
Inclusion criteria as written on the registry, trimmed. The full list, with exclusions, is on the live record.
For you, or someone you love
A complex diagnosis brings new questions every week, in a trial and out of one. Triangle keeps your whole medical file together, reads it with you in plain language, and helps you and your family decide what to ask next.
Then $9 a month. Cancel anytime.
Requested from your hospitals and clinics through the national networks. Add scans, pathology and anything on paper.
Reports explained as they come in, with lab values you can follow before treatment, during a trial and after.
Ask about your own file, and walk in with questions for your oncologist or the trial team.
Share one profile with the family helping you, and with your doctors.
Members also get a deeper analysis of their records and any sequencing data, including clinical trials that may fit, reviewed by a licensed physician before they receive it.
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.
How these trials work: what Phase 1 actually is · common questions Not clinical evidence.